HELIUS MEDICAL TECHNOLOGIES, INC. 2,121,212 Shares of Class A Common Stock (par value $0.001 per share) Underwriting AgreementUnderwriting Agreement • November 16th, 2018 • Helius Medical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 2,121,212 shares (the “Firm Securities”) of its Class A Common Stock, par value $0.001 per share (the “Class A Common Stock”). In addition, the Company has granted to the Underwriters (as defined below) an option to purchase, in the aggregate, up to an additional 318,182 Class A Common Stock (the “Option Securities”). The Firm Securities and, if and to the extent such option is exercised, the Option Securities, are collectively called the “Offered Securities.” BTIG, LLC (“BTIG”) and Oppenheimer & Co. Inc. (“Oppenheimer”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offered Securities. To the extent there are no additional underwriters listed on Schedule A hereto, the term “Representatives” as
